A Careful Bridge Between Patients and Medical Care in China
We support international patients and families with structured medical information review, bilingual dossier preparation, and accredited Class 3A hospital coordination before cross-border treatment decisions.
A Specialized Medical Review & Coordination Bureau
MedJourney China is a cross-border medical information review and coordination service for international patients seeking care options in China. We focus on oncology, orthopedics, and nephrology-related case support, bridging the clinical language and administrative gap before families commit to international travel.
Medical Record Organization & Dossier Synthesis
We compile fragmented clinical notes, biopsy slides, histology panels, and multi-slice DICOM imaging into a structured, chronological medical dossier standardized for Chinese specialist review.
Preliminary Review Coordination
We coordinate administrative reviews with accredited medical departments to evaluate whether a case meets criteria for tertiary intervention, innovative clinical regimens, or advanced surgical care.
Hospital Department Matching Communication
Direct alignment with National Medical Centers and accredited Class 3A hospital departments in Shanghai, Beijing, Guangzhou, and Hangzhou, matching exact clinical sub-specialties.
Designed for South Asian Families Seeking Cross-Border Clinical Certainty
Cross-border care is a profound family commitment. We specialize in serving patients from Bangladesh and neighboring South Asian communities requiring disciplined clarity before travel.
Bangladesh Patients & Families
Families navigating high-stakes medical conditions who want verified Class 3A options in China without navigating bureaucratic and language barriers unassisted.
Oncology, Orthopedic & Nephrology Cases
Patients seeking advanced cellular therapies, specialized spine and joint revision surgery, or complex chronic kidney disease preservation protocols.
Caregivers Comparing International Options
Families actively benchmarking treatment horizons between Singapore, Thailand, India, and China, seeking clear capability, cost transparency, and clinical protocol differences.
English & Bangla Medical Record Conversion
Patients with comprehensive records in English or Bengali who need clinical translation into standardized Chinese clinical terminology recognized by medical chiefs.
Discerning Families Demanding Strict Confidentiality
High-net-worth clients who require dedicated liaison handling, discreet family advisory rooms, zero data leakage, and sovereign institutional matching without public commercial disclosure.
End-to-End Administrative & Information Stewardship
We handle the complex clinical translation and coordination framework so families can focus on care decisions rather than logistical confusion.
Raw Record Intake
Submit your medical records in their original format. Patients do not need costly, certified pre-translations before submitting their preliminary case documents.
DICOM & Imaging Normalization
We extract and curate high-resolution CT, MRI, and PET scans into Chinese clinical imaging platforms, ensuring hospital department chiefs can review uncompressed studies immediately.
Medical Translation & Dossier Synthesis
Our clinical translators prepare bilingual summaries formatted specifically for China's Class 3A clinical evaluation standards, highlighting key biomarkers and previous therapeutic lines.
Class 3A Department Direction
We identify accredited hospital departments with specific, verified clinical capability matching the patient’s disease stage, molecular sub-type, or surgical complexity.
Continuous Encrypted Updates
Receive structured status reports through direct WhatsApp channels and encrypted email, managed cooperatively by our Dhaka liaison desk and Shanghai coordination team.
Clear Fee & Cost Transparency
Every step is outlined upfront. The flat $300 preliminary review fee is clearly demarcated from expected hospital inpatient deposits, travel, and accommodation requirements.
Clear Commitments to What We Do Not Do
Ethical stewardship requires strict boundaries. We do not make promises that compromise patient safety, sovereign law, or clinical objectivity.
We do not diagnose disease or replace hands-on medical evaluations. Official diagnosis rests solely with licensed physicians during in-person institutional admission.
We never guarantee survival rates, surgical success, or specific pharmacological responses. All treatments carry inherent clinical uncertainty.
Hospital admission, ICU bed priority, and surgical scheduling remain at the sole clinical discretion of Chinese hospital administrators and department chairs.
We strictly reject, prohibit, and do not participate in organ brokerages, non-relative donor sourcing, or commercial transplant transactions under any circumstances.
We are an elective medical dossier review and institutional matching service. We cannot handle acute resuscitation, active trauma, or immediate critical ambulance evacuations.
While we facilitate hospital invitation letters for Medical Visa (S2) issuance, consular approvals are under the sovereign authority of the Embassy of the People's Republic of China.
Guided by Clinical Respect, Patient Sovereignty, and Transparency
Our operating philosophy centers on minimizing disruption for patients dealing with profound illness.
Clarity Before Travel
Families must never undertake grueling cross-border flights on speculation. We require preliminary department alignment and clear feasibility roadmaps before recommending international travel.
Privacy & Data Stewardship
Medical records contain intensely personal history. Our data processing adheres to high standards of cross-border data protection, zero marketing leaks, and confidential patient handling.
Transparent Fee Separation
We operate under a flat $300 institutional review fee. We do not mark up hospital medical bills, conceal tertiary fee schedules, or take kickbacks from pharmacological prescriptions.
Deep Competence Across Three Core Specialties
Rather than general brokering, MedJourney China concentrates its academic relationships and review protocols on three complex tertiary areas.
Oncology
精密肿瘤与靶向治疗Review of molecular pathology reports, genetic mutation profiles, previous systemic lines, and Class 3A department matching for CAR-T, immunotherapy, and heavy ion radiotherapy.
Orthopedics
复杂骨科与脊柱修复Coordination for joint revision, severe spinal scoliosis and deformity correction, robotic minimally invasive decompression, and complex pelvic reconstructive surgery.
Nephrology
肾病科与透析通络管理Comprehensive staging audit for chronic kidney disease (CKD Stages 3-5), vascular access revision, glomerular disease treatment protocols, and ethical statutory kidney care pathways.
Bridging Dhaka to China's Leading Medical Hubs
We understand the emotional and practical hurdles faced by Bangladeshi families seeking treatment abroad. Our dedicated liaison infrastructure offers culturally respectful, uninterrupted communication.
Immediate connection through WhatsApp with dedicated Bangladesh time zone coverage, enabling continuous updates without international call delays.
Comprehensive dossier briefings provided in English and Bengali so multi-generational family decision-makers share full clarity.
Coordinating cases from Dhaka, Chittagong, Sylhet, and Bangladeshi diaspora communities residing in the GCC and North America.
Respectful guidance respecting family consensus, dietary/halal lodging questions near Shanghai hospitals, and visa sponsorship support.
Start With a Clear Medical Review
Upload your records and understand the next steps before deciding whether treatment in China is right for your situation. Our coordinators assist you at every checkpoint.
MedJourney China provides medical information review and coordination support. It does not guarantee diagnosis, treatment availability, hospital admission, visa approval, or medical outcomes. All tertiary clinical decisions remain under the sovereign authority of licensed Chinese hospital medical teams.